Overview
- 6 inspections across 6 sites are on record.
- 18 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-19.
At a glance
Inspections
6
Sites
6
Observations
18
Career since
Aug 2024
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Lonza Bend Inc. | 19 May 2026 | Human Drugs | View 483 → |
| Pacira Pharmaceuticals, Inc. | 25 Mar 2026 | Human Drugs | On file |
| Pyramid Laboratories, Inc. | 13 Feb 2026 | Human Drugs | View 483 → |
| L. Perrigo Company | 19 Mar 2025 | Human Drugs | View 483 → |
| Baxter Corporation | 31 Jan 2025 | Human Drugs | View 483 → |
Sites inspected
Lonza Bend Inc.Bend, United States1 insp.
Pacira Pharmaceuticals, Inc.San Diego, United States1 insp.
Pyramid Laboratories, Inc.Costa Mesa, United States1 insp.
L. Perrigo CompanyAllegan, United States1 insp.
Baxter CorporationAlliston, Canada1 insp.
Co-investigators
Investigators who share inspections with this person.
Alexandra A Cole1 shared
Aranjeet Singh1 shared
Gloria E Andia1 shared
Navneet Kaur1 shared
Conor J Mccarron1 shared
Eric Zhu1 shared
Homero W Aguilar1 shared
Sara H Gabel1 shared
Cecilia H Kieu1 shared
Joan M Cantellops Figueroa1 shared
Full investigator report
Get the verbatim findings behind Ana-Maria A Plapcianu's 18 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site